Click below to view the webcast from Corbus’ first R&D Day held March 13, 2017
Acknowledgements of Applicants for Expanded Access to Corbus Pharmaceuticals Holdings, Inc. Products
Corbus Expanded Access Program Physician Request Form
Corbus Pharmaceuticals is a clinical stage biopharmaceutical company focusing on rare, life-threatening, chronic inflammatory diseases.
Corbus Pharmaceuticals is developing anabasum for the treatment of chronic ("orphan") inflammatory diseases in which inflammation leads to chronic fibrosis.